SCHEMBL4062497

SCHEMBL4062497

O=C(O)[N+]1([O-])CCCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4059820 1.00
SCHEMBL1238338 1.00
SCHEMBL431934 0.97
SCHEMBL2225149 0.91
SCHEMBL641601 0.74 TSHR (0.32)
SCHEMBL14915497 0.74
SCHEMBL9800820 0.72
SCHEMBL542161 0.71 SLC6A1 (0.34)
SCHEMBL14914735 0.71
SCHEMBL4362207 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2855476-A2 TETRAHYDROPYRAZOLOPYRIMIDINE COMPOUNDS Eisai R&D Management Co., Ltd. (JP) 2015-04-08 EP disclosed
WO-2013181579-A2 TETRAHYDROPYRAZOLOPYRIMIDINE COMPOUNDS EISAI R & D MANAGEMENT CO., LTD. (JP) 2013-12-05 WO disclosed
EP-2069347-A2 NOVEL INHIBITORS OF BETA-LACTAMASE Merck & Co., Inc. (US) 2009-06-17 EP disclosed
WO-2008039420-A2 NOVEL INHIBITORS OF BETA-LACTAMASE MERCK & CO., INC. (US) 2008-04-03 WO disclosed
EP-1871761-A2 SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS OF THEIR USE Adolor Corporation (US) 2008-01-02 EP disclosed
WO-2006105442-A2 SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS OF THEIR USE ADOLOR CORPORATION (US) 2006-10-05 WO disclosed